Literature DB >> 15180520

Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins.

A Jennifer Rivett1, Arron R Hearn.   

Abstract

Proteasomes are the major nonlysosomal protein degradation machinery in eukaryotic cells and they are largely responsible for the processing of antigens for presentation by the MHC class I pathway. This review concentrates on recent developments in the area of antigen processing. Specialized proteasomes called immunoproteasomes and an 11S regulator of proteasomes (PA28) are induced by interferon-gamma, but it is not entirely clear why changes in proteasome structure are beneficial for antigen presentation. Different proteasome complexes have distinct subcellular distributions and subtle differences in cleavage specificity. Thus it is likely that the efficiency of production of MHC class I binding peptides varies in different locations. Immunoproteasome subunits are enriched at the ER where TAP transports peptides for association with newly synthesized MHC class I molecules. There is recent evidence to suggest that antigen presentation from viral expression vectors, or from peptides that are either delivered by bacterial toxins or derived from signal peptides, require proteasome activity for generation of the correct C-terminus of the epitope. The correct N-terminus may be generated by recently identified ER associated aminopeptidases. A number of viral protein interactions with proteasome subunits have been reported and such interactions may interfere with host anti-viral defenses and also contribute to mechanisms of cell transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180520     DOI: 10.2174/1389203043379774

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  38 in total

1.  Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity.

Authors:  Yin Liu; Yuval Ramot; Antonio Torrelo; Amy S Paller; Nuo Si; Sofia Babay; Peter W Kim; Afzal Sheikh; Chyi-Chia Richard Lee; Yongqing Chen; Angel Vera; Xue Zhang; Raphaela Goldbach-Mansky; Abraham Zlotogorski
Journal:  Arthritis Rheum       Date:  2012-03

Review 2.  The immunoproteasome as a target in hematologic malignancies.

Authors:  Deborah J Kuhn; Robert Z Orlowski
Journal:  Semin Hematol       Date:  2012-07       Impact factor: 3.851

Review 3.  Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Authors:  L Morici; A G Torres; R W Titball
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

4.  Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.

Authors:  Yoshinori Ito; Eisei Kondo; Ayako Demachi-Okamura; Yoshiki Akatsuka; Kunio Tsujimura; Mitsune Tanimoto; Yasuo Morishima; Toshitada Takahashi; Kiyotaka Kuzushima
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  Implication of altered proteasome function in alcoholic liver injury.

Authors:  Natalia A Osna; Terrence-M Donohue
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

6.  Nuclear effects of ethanol-induced proteasome inhibition in liver cells.

Authors:  Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

7.  Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes.

Authors:  Gudrun Szalay; Silke Meiners; Antje Voigt; Jörg Lauber; Christian Spieth; Nora Speer; Martina Sauter; Ulrike Kuckelkorn; Andreas Zell; Karin Klingel; Karl Stangl; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Clinical and serological features of patients with autoantibodies to GW/P bodies.

Authors:  Rahima A Bhanji; Theophany Eystathioy; Edward K L Chan; Donald B Bloch; Marvin J Fritzler
Journal:  Clin Immunol       Date:  2007-09-17       Impact factor: 3.969

9.  Chronic ethanol feeding affects proteasome-interacting proteins.

Authors:  Marie-Pierre Bousquet-Dubouch; Sheila Nguen; David Bouyssié; Odile Burlet-Schiltz; Samuel W French; Bernard Monsarrat; Fawzia Bardag-Gorce
Journal:  Proteomics       Date:  2009-07       Impact factor: 3.984

10.  Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors.

Authors:  Deborah J Kuhn; Sally A Hunsucker; Qing Chen; Peter M Voorhees; Marian Orlowski; Robert Z Orlowski
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.